公开(公告)号：US20220339215A1

公开(公告)日：2022-10-27

申请号：US17666034

申请日：2022-02-07

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： REMY BURCELIN ,  DIDIER CARCANO ,  SAMPO LAHTINEN ,  LOTTA STENMAN ,  JOHN KONHILAS

IPC: A61K35/745 ,  A23C9/123 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A61K31/155 ,  A61K31/715 ,  A61K35/744 ,  A61K35/747 ,  A23L33/135

Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.

公开(公告)号：US20240335485A1

公开(公告)日：2024-10-10

申请号：US18497412

申请日：2023-10-30

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： REMY BURCELIN ,  DIDIER CARCANO ,  SAMPO LAHTINEN ,  LOTTA STENMAN ,  JOHN KONHILAS

IPC: A61K35/745 ,  A23C9/123 ,  A23L33/135 ,  A61K31/155 ,  A61K31/715 ,  A61K35/00 ,  A61K35/744 ,  A61K35/747 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06

CPC classification number: A61K35/745 ,  A23C9/1234 ,  A23L33/135 ,  A61K31/155 ,  A61K31/715 ,  A61K35/744 ,  A61K35/747 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2200/326 ,  A23V2200/328 ,  A23V2200/332 ,  A23V2400/181 ,  A23V2400/51 ,  A23V2400/515 ,  A23V2400/531 ,  A61K2035/115 ,  A61K2300/00

Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.

公开(公告)号：US20180207209A1

公开(公告)日：2018-07-26

申请号：US15927986

申请日：2018-03-21

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： REMY BURCELIN ,  DIDIER CARCANO ,  SAMPO LAHTINEN ,  LOTTA STENMAN ,  JOHN KONHILAS

IPC: A61K35/745 ,  A23C9/123 ,  A61K31/155 ,  A61K31/715 ,  A61K35/744 ,  A61K35/747 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A61K35/00

CPC classification number: A61K35/745 ,  A23C9/1234 ,  A23L33/135 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2200/326 ,  A23V2200/328 ,  A23V2200/332 ,  A23Y2220/79 ,  A23Y2300/00 ,  A23Y2300/21 ,  A23Y2300/49 ,  A61K31/155 ,  A61K31/715 ,  A61K35/744 ,  A61K35/747 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A61K2035/115 ,  A61K2300/00

Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.